News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
3h
Vietnam Investment Review on MSNWhat lies ahead through US drug pricing shake upDuyen Ha Vo, senior partner, Vilaf Finished pharmaceutical products were initially excluded from US President Donald Trump’s reciprocal tariff regime announced in April. However, President Trump ...
The Trump administration hopes to issue a rule by the end of this year empowering regulators to “very forcefully” go after ...
Prescription drug prices are a major concern for people, healthcare professionals, and policymakers. Even for those with insurance, out-of-pocket costs can still be high.
A 2024 RAND report found that while name-brand drugs in the U.S. were "422 percent of prices in comparison countries," unbranded generics—which make up 90 percent of all prescriptions dispensed ...
A fact sheet on Trump’s executive order correctly said that the net price people in the U.S. pay for brand-name drugs averages “more than three times the price other OECD nations pay.” ...
If, however, the policy does not succeed in lowering prices, the executive order also empowers the secretary of health and human services to issue waivers to the Food and Drug Administration to ...
The chart gives U.S. prescription drug prices along with drug prices in seven other rich countries: Canada, France, Germany, Italy, Japan, Mexico and the United Kingdom.
Prescription drugs are pricier in the U.S. than in other countries, according to a 2024 report he co-authored. But the overall price gap is not as high as Trump said.
To really change how drug prices are negotiated in the U.S., Congress would need to act, she said. Plus, "Pharmaceutical companies are among the biggest lobbying presences in Washington, D.C.
US President Donald Trump plans to slash prices of prescription drugs in the country by 30-80%. How will this impact Indian drugmakers, who mostly ship relatively inexpensive generic medicines to ...
Prescription drug prices still surging despite efforts by federal government Consumers spent $61 billion on out-of-pocket prescriptions last year, per GoodRX Prescription Cost Tracker Comments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results